Psychoactive drugs

Orbit Coffee Uses Maca Root To Keep Customers Focused

Retrieved on: 
Friday, July 30, 2021
Psychoactive drugs, Drugs, Food and drink, Crops, Flora of Peru, Lepidium meyenii, Caffeine, Coffee

Along with carefully formulated caffeine, coffee, and carbohydrates, the energy booster also utilizes the Peruvian wonder veggie Maca root to enhance its formula and make it more effective.

Key Points: 
  • Along with carefully formulated caffeine, coffee, and carbohydrates, the energy booster also utilizes the Peruvian wonder veggie Maca root to enhance its formula and make it more effective.
  • One of the biggest factors that helps Orbit Coffee stand out from the crowd, though, is its use of Maca root.
  • Along with adding an earthy, nutty flavor to the overall mixture, the Maca root present in Orbit Coffee can help boost performance, raise energy levels, improve mood, and enhance overall cognition.
  • About Orbit Coffee: Orbit Coffee is a product created by Cleverit Corp.

Braxia Scientific Provides Corporate Update and Reports Fiscal Fourth Quarter and Full-Year 2021 Financial Results

Retrieved on: 
Friday, July 30, 2021
Psychoactive drugs, Drugs, Health sciences, Antidepressants, General anesthetics, Arylcyclohexylamines, Nicotinic antagonists, Sedatives, Ketamine, Therapy, Bipolar disorder, Mental health

Through its global leading researchers and experienced implementation team, Braxia Scientific has established its presence in the mental health industry.

Key Points: 
  • Through its global leading researchers and experienced implementation team, Braxia Scientific has established its presence in the mental health industry.
  • Braxia Health is the first to offer novel Ketamine therapy, including intravenous therapy, to patients in a private clinical setting in Quebec.
  • In June 2021, the Company announced that Chief Medical and Scientific Officer Dr. Joshua Rosenblat, will initiate a first-of-its-kind ketamine clinical trial to treat bipolar depression.
  • "Braxia Scientific has achieved significant milestones to date, and we are picking up the pace," noted CEO Dr. Roger McIntyre.

New Truth Initiative Study Finds That E-Cigarette Use Increases Odds Of Youth Using Cigars, Little Cigars Or Cigarillos (CLCCs)

Retrieved on: 
Thursday, July 29, 2021
Electronic cigarettes, Tobacco, Smoking, Psychoactive drugs, Electronic cigarette, Cigar, Flavored tobacco, Usage of electronic cigarettes

This study is the first to find that using e-cigarettes strongly predicts future use of cigars, little cigars or cigarillos (CLCCs) and flavored CLCCsproducts thatpresent the same health risks as combustible cigarettes.

Key Points: 
  • This study is the first to find that using e-cigarettes strongly predicts future use of cigars, little cigars or cigarillos (CLCCs) and flavored CLCCsproducts thatpresent the same health risks as combustible cigarettes.
  • This group had 2.5x higher odds of using flavored CLCCs compared to non-flavored CLCCs.
  • Flavors, including menthol, are a key factor in hooking youth and young adults on tobacco products.
  • In 2020, 82.9% of youth who vape used flavored e-cigarettes, including 84.7% of high school users and 73.9% of middle school users.

Next Frontier Brands' Subsidiary TreeHouse Biosciences™ Announces the Launch of its THC Remediation Services Business Based on Patented Technology

Retrieved on: 
Thursday, July 29, 2021
Euphoriants, Entheogens, Appetite stimulants, Drugs, Psychoactive drugs, Medical specialties, Herbs, Antiemetics, Hemp, Tetrahydrocannabinol, Cannabinoid, Cannabis

This method utilizes chromatography, a process which separates chemical compounds based on their unique molecular properties.

Key Points: 
  • This method utilizes chromatography, a process which separates chemical compounds based on their unique molecular properties.
  • TreeHouse Biosciences also has filed a patent for the removal of THC from hemp extracts utilizing a mild combination of heat and oxygen.
  • Treehouse Biosciencesnow provides THC remediation services through its Boulder, Colorado operations, and intends to build remote modular processing units in selected states where hemp processing is prominent.
  • Treehouse Biosciencesis a leader in the research, development and production of hemp-derived cannabinoid ingredients,and purification and remediation technologies.

CPG Manufacturer Global Widget to Showcase Leading CBD, Health and Wellness Brands at ASD Market Week in Las Vegas, Aug. 22-24

Retrieved on: 
Thursday, July 29, 2021
Psychoactive drugs, Analgesics, Wellness, Widget, Hemp, Mitragyna speciosa, Clinical medicine, Medical specialties

TAMPA, Fla., July 29, 2021 /PRNewswire/ --Global Widget, the manufacturer and distributor of the iconic CBD brand Hemp Bombs , will be showcasing its newest alternative health and wellness brands at ASD Market Week, Aug. 22-24 in Las Vegas at the Las Vegas Convention Center.

Key Points: 
  • TAMPA, Fla., July 29, 2021 /PRNewswire/ --Global Widget, the manufacturer and distributor of the iconic CBD brand Hemp Bombs , will be showcasing its newest alternative health and wellness brands at ASD Market Week, Aug. 22-24 in Las Vegas at the Las Vegas Convention Center.
  • In addition to its Hemp Bombs brand, Global Widget will feature its newest product lines Mystic Labs , Black Diamond Kratom , hyperbrain iQ and Forever Well Nutrition .
  • "As a leading distributor and manufacturer of premium CBD and alternative health and wellness products, ASD Market Week allows us to see our long-time distributor and retail partners face to face," said Vince Gillen, Vice President of Sales.
  • To book an appointment with Global Widget during ASD Market Week, retailers can visit Global Widget's online portal for ASD here .

Thompson Duke Industrial Releases Automated Vaporizer Filling Machine To Increase Process Efficiencies

Retrieved on: 
Thursday, July 29, 2021
Euphoriants, Psychoactive drugs, Entheogens, Medicinal plants, Cannabis smoking, Health sciences, Pharmacology, Dosage forms, Cannabis, Vaporizer, Hash oil

PORTLAND, Ore., July 29, 2021 /PRNewswire/ -- Thompson Duke Industrial , the leader in cannabis oil vaporizer device filling and capping equipment, has released its IZR Automatic Filling Machine .

Key Points: 
  • PORTLAND, Ore., July 29, 2021 /PRNewswire/ -- Thompson Duke Industrial , the leader in cannabis oil vaporizer device filling and capping equipment, has released its IZR Automatic Filling Machine .
  • "The IZR is a great example of Thompson Duke responding to the needs of the industry to solve a complex problem with a simple design," saidChris Gardella, Chief Technology Officer forThompson Duke Industrial.
  • Existing clients can readily upgrade their systems to IZR capabilities, as the machine works with all existing Thompson Duke Industrial ACF1 trays and components.
  • With over 1,200 filling machines deployed in the cannabis industry, Thompson Duke Industrial is the leader in cannabis oil vaporizer device filling and capping equipment.

Khiron Welcomes Dr. Eduardo Faveret as Medical Director for Brazil

Retrieved on: 
Thursday, July 29, 2021
Psychoactive drugs, Health sciences, Herbalism, Medicinal plants, Cannabis smoking, Cannabis, Entheogens, Medical cannabis, Legality of cannabis, Effects of cannabis

Dr. Faveret is a prominent advocate for medical cannabis in Brazil and a leading prescriber in the country of more than 200 million people.

Key Points: 
  • Dr. Faveret is a prominent advocate for medical cannabis in Brazil and a leading prescriber in the country of more than 200 million people.
  • Dr. Faveret boasts a highly distinguished medical and academic career, as the founder and former medical director of the Epilepsy Center at the Paulo Niemeyer State Brain Institute in Rio de Janeiro.
  • Alvaro Torres, Khiron CEO and Director, commented: "We are thrilled to welcome Dr. Faveret to our team.
  • With over eight years' experience helping patients access medical cannabis, Dr. Faveret is a leading medical cannabis specialist in Brazil who shares our mission of improving patients' lives through medical cannabis.

Companies Smashing the Psychedelic Ceiling

Retrieved on: 
Thursday, July 29, 2021
Psychoactive drugs, Entheogens, Hallucinations, Mycotoxins, Organophosphates, Psilocybin, Psychedelic drug, Drug

Most psychedelic drug developers are working on drugs for mental illness, particularly depression; Tryp is targeting chronic pain and eating disorders.

Key Points: 
  • Most psychedelic drug developers are working on drugs for mental illness, particularly depression; Tryp is targeting chronic pain and eating disorders.
  • Tryp Therapeutics is advancing novel drug candidates made from psilocybin, the psychedelic component found in magic mushrooms.
  • Only an elite group of companies have initiated Phase 2 clinical trials exploring psychedelic-related compounds; those companies' valuation ranges from $85 million to $2.5 billion versus Tryp's $31 million.
  • To do so, Tryp has teamed up with leading companies whose expertise will be invaluable in its development.

Companies Smashing the Psychedelic Ceiling

Retrieved on: 
Thursday, July 29, 2021
Psychoactive drugs, Entheogens, Hallucinations, Mycotoxins, Organophosphates, Psilocybin, Psychedelic drug, Drug

NEW YORK, July 29, 2021 /PRNewswire/ -- It's early on in a burgeoning market, but there is certainly reason to be optimistic about the future of psychedelic medicines as a promising treatment for a broad spectrum of diseases and conditions. In fact, some breakthroughs may be closer than initially anticipated. After decades of stigma from their recreational use, psychedelics are now gaining momentum for medical applications as the U.S. Food and Drug Administration has signaled its intent to evaluate the compounds based on the merit of their clinical efficacy. The range of target indications is widening, the number of studies for different types of psychedelics is growing and specialized clinics are cropping up, a trio of signals that approved medical applications of psychedelics may be here before long. The diversity of approaches makes the market particularly interesting for psychedelic market participants. For instance, Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (Profile) is studying how its novel technologies address chronic pain and eating disorders — two areas that have been particularly elusive for traditional drug makers. Seelos Therapeutics Inc. (NASDAQ: SEEL) is looking at a new spin on ketamine for certain types of depression, while Awakn Life Sciences Corp. (NEO: AWKN) and Field Trip Health Ltd. (TSX: FTRP) (OTCQX: FTRPF) are in the clinics and R&D businesses, and Small Pharma Inc. (TSX.V: DMT) is evaluating other psychedelics for depression.

Key Points: 
  • Most psychedelic drug developers are working on drugs for mental illness, particularly depression; Tryp is targeting chronic pain and eating disorders.
  • Tryp Therapeutics is advancing novel drug candidates made from psilocybin, the psychedelic component found in magic mushrooms.
  • Only an elite group of companies have initiated Phase 2 clinical trials exploring psychedelic-related compounds; those companies' valuation ranges from $85 million to $2.5 billion versus Tryp's $31 million.
  • To do so, Tryp has teamed up with leading companies whose expertise will be invaluable in its development.

Lantern Expands On-Demand Recreational Cannabis Delivery to Grand Rapids

Retrieved on: 
Thursday, July 29, 2021
Herbalism, Medicinal plants, Health sciences, Cannabis smoking, Psychoactive drugs, Medicine, Cannabis, Entheogens, Medical cannabis, Effects of cannabis, Draft:Verda

GRAND RAPIDS, Mich., July 29, 2021 /PRNewswire/ -- Lantern , the leading on-demand cannabis e-commerce marketplace and home delivery platform in the U.S., today launched on-demand recreational cannabis delivery in Grand Rapids, becoming the first marketplace to offer delivery in Michigan's second largest city.

Key Points: 
  • GRAND RAPIDS, Mich., July 29, 2021 /PRNewswire/ -- Lantern , the leading on-demand cannabis e-commerce marketplace and home delivery platform in the U.S., today launched on-demand recreational cannabis delivery in Grand Rapids, becoming the first marketplace to offer delivery in Michigan's second largest city.
  • Lantern has been serving Michigan consumers since October 2020 when it became the first platform to launch on-demand delivery in Detroit.
  • Recreational consumers in Grand Rapids can now order their favorite products and brands directly from LanternNow.com and receive their orders in 60 minutes or less.
  • Lantern is the leading cannabis e-commerce marketplace and delivery platform in the U.S. With the speed and convenience of on-demand delivery, Lantern partners with the best local dispensaries and cannabis brands to bring transparency, safety, and access to cannabis for both new and experienced consumers through intuitive, personalized shopping experiences.